---
title: "EMTX.US (EMTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EMTX.US/news.md"
symbol: "EMTX.US"
name: "EMTX.US"
parent: "https://longbridge.com/en/quote/EMTX.US.md"
datetime: "2026-03-14T03:04:47.482Z"
locales:
  - [en](https://longbridge.com/en/quote/EMTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EMTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EMTX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/EMTX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/EMTX.US/news.md)


# EMTX.US (EMTX.US) — Related News

### [Eliem Therapeutics (NASDAQ:ELYM) Trading Down 2.8%  - Here's What Happened](https://longbridge.com/en/news/278501690.md)
*2026-03-10T06:34:53.000Z*
> Eliem Therapeutics (NASDAQ:ELYM) saw its stock price decline by 2.8% during trading on Monday, closing at $7.18 after re

### [06:00 ETP-Cure Announces First-Ever Prospective Clinical Results of Gantry-Less Upright Proton Therapy for Lung Cancer Re-Irradiation](https://longbridge.com/en/news/276051972.md)
*2026-02-16T11:02:17.000Z*
> P-Cure announced the first prospective clinical results of gantry-less upright proton therapy for lung cancer re-irradia

### [Eliem Therapeutics (NASDAQ:ELYM) Trading Up 1.1%  - Still a Buy?](https://longbridge.com/en/news/275876029.md)
*2026-02-13T09:13:18.000Z*
> Eliem Therapeutics (NASDAQ:ELYM) saw its stock price increase by 1.1% to $5.56 during trading, with a market cap of $165